TY - JOUR
T1 - Improving medical care and prevention in adults with congenital heart disease—reflections on a global problem—part I
T2 - Development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia
AU - Neidenbach, Rhoia
AU - Niwa, Koichiro
AU - Oto, Oeztekin
AU - Oechslin, Erwin
AU - Aboulhosn, Jamil
AU - Celermajer, David
AU - Schelling, Joerg
AU - Pieper, Lars
AU - Sanftenberg, Linda
AU - Oberhoffer, Renate
AU - De Haan, Fokko
AU - Weyand, Michael
AU - Achenbach, Stephan
AU - Schlensak, Christian
AU - Lossnitzer, Dirk
AU - Nagdyman, Nicole
AU - Von Kodolitsch, Yskert
AU - Kallfelz, Hans Carlo
AU - Pittrow, David
AU - Bauer, Ulrike M.M.
AU - Ewert, Peter
AU - Meinertz, Thomas
AU - Kaemmerer, Harald
N1 - Publisher Copyright:
© Cardiovascular Diagnosis and Therapy. All rights reserved.
PY - 2018/12
Y1 - 2018/12
N2 - Today most patients with congenital heart defects (CHD) survive into adulthood. Unfortunately, despite relevant residua and sequels, follow-up care of adults with congenital heart disease (ACHD) is not performed in specialized and/or certified physicians or centres. Major problems in the long-term course encompass heart failure, cardiac arrhythmias, heart valve disorders, pulmonary vascular disease, infective endocarditis, aortopathy and non-cardiac comorbidities. Many of them manifest themselves differently from acquired heart disease and therapy regimens from general cardiology cannot be transferred directly to CHD. It should be noted that even simple, postoperative heart defects that were until recently considered to be harmless can lead to problems with age, a fact that had not been expected so far. The treatment of ACHD has many special features and requires special expertise. Thereby, it is important that treatment regimens from acquired heart disease are not necessarily transmitted to CHD. While primary care physicians have the important and responsible task to set the course for adequate diagnosis and treatment early and to refer patients to appropriate care in specialized ACHD-facilities, they should actively encourage ACHD to pursue follow-up care in specialized facilities who can provide responsible and advanced advice. This medical update emphasizes the current data on epidemiology, heart failure and cardiac arrhythmia in ACHD.
AB - Today most patients with congenital heart defects (CHD) survive into adulthood. Unfortunately, despite relevant residua and sequels, follow-up care of adults with congenital heart disease (ACHD) is not performed in specialized and/or certified physicians or centres. Major problems in the long-term course encompass heart failure, cardiac arrhythmias, heart valve disorders, pulmonary vascular disease, infective endocarditis, aortopathy and non-cardiac comorbidities. Many of them manifest themselves differently from acquired heart disease and therapy regimens from general cardiology cannot be transferred directly to CHD. It should be noted that even simple, postoperative heart defects that were until recently considered to be harmless can lead to problems with age, a fact that had not been expected so far. The treatment of ACHD has many special features and requires special expertise. Thereby, it is important that treatment regimens from acquired heart disease are not necessarily transmitted to CHD. While primary care physicians have the important and responsible task to set the course for adequate diagnosis and treatment early and to refer patients to appropriate care in specialized ACHD-facilities, they should actively encourage ACHD to pursue follow-up care in specialized facilities who can provide responsible and advanced advice. This medical update emphasizes the current data on epidemiology, heart failure and cardiac arrhythmia in ACHD.
KW - Congenital heart defect (CHD)
KW - Endocarditis
KW - Heart failure
KW - Primary health care
KW - Pulmonary hypertension
UR - http://www.scopus.com/inward/record.url?scp=85059646002&partnerID=8YFLogxK
U2 - 10.21037/cdt.2018.10.15
DO - 10.21037/cdt.2018.10.15
M3 - Review article
AN - SCOPUS:85059646002
SN - 2223-3652
VL - 8
SP - 705
EP - 715
JO - Cardiovascular Diagnosis and Therapy
JF - Cardiovascular Diagnosis and Therapy
IS - 6
ER -